Pharmacology of Antiemetics

International Anesthesiology Clinics

Volumn 41, Issue 4, 2003, Pages 41-66

  Scuderi, Phillip E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE MALEATE; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZAMIDE DERIVATIVE; BETAMETHASONE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLIZINE; DEXAMETHASONE; DIMENHYDRINATE; DIPHENHYDRAMINE; DOLASETRON MESILATE; DOMPERIDONE; DROPERIDOL; FLUPHENAZINE; FLUPHENAZINE DECANOATE; GRANISETRON; HALOPERIDOL; HYDROXYZINE; MECLOZINE; METOCLOPRAMIDE; ONDANSETRON; PERPHENAZINE; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; PROMETHAZINE; RAMOSETRON; SCOPOLAMINE; SEROTONIN ANTAGONIST; STEROID; TROPISETRON; UNINDEXED DRUG;

AGITATION; AKATHISIA; AMNESIA; ANXIETY; ASTHENIA; ATAXIA; BLOOD TOXICITY; BURNING SENSATION; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM DEPRESSION; CHOLESTASIS; CLINICAL PRACTICE; CONFUSION; CONSTIPATION; DEATH; DIARRHEA; DISORIENTATION; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DYSPHORIA; DYSTONIA; ELECTROLYTE BALANCE; EXTRAPYRAMIDAL SYMPTOM; FEVER; FLUSHING; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; INSOMNIA; JAUNDICE; LETHARGY; MOTOR DYSFUNCTION; MYALGIA; NAUSEA; NERVOUSNESS; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSONISM; PATIENT CARE; PERINEUM INJURY; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; PROPHYLAXIS; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SKIN SENSITIZATION; SOMNOLENCE; STOMACH MOTILITY; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TARDIVE DYSKINESIA; THIRST; TORSADE DES POINTES; TREMOR; URINE RETENTION; VERTIGO; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIEMETICS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HUMANS; INFANT; POSTOPERATIVE NAUSEA AND VOMITING;

EID: 0142126367     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200341040-00006     Document Type: Review

References (98)

1. Kapur PA. The big "little problem." Anesth Analg 1991;73:243-245
2. Aapro M. Methodological issues in antiemetic studies. Invest New Drugs 1993;11:243-253
3. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992;77:162-184
4. Apfel CC, Greim CA, Haubitz I, et al. A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand 1998;42:495-501
5. Koivuvanta M, Läärä E, Snåre L, et al. A survey of postoperative nausea and vomiting. Anaesthesia 1997;52:443-449
6. Palazzo M, Evans R. Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk assessment. Br J Anaesth 1993;70:135-140
7. Ebherhart LHJ, Högel J, Seeling W, et al. Evaluation of three risk scores to predict postoperative nausea and vomiting. Acta Anaesthesiol Scand 2000;44:480-488
8. Apfel CC, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology 1999;91:693-700
9. Wu CL, Berenholtz SM, Pronovost PJ, et al. Systematic review and analysis of post-discharge symptoms after outpatient surgery. Anesthesiology 2002;96:994-1003
10. Mitchelson F. Pharmacological agents affecting emesis: a review (part I). Drugs 1992;43:295-315
11. Mitchelson F. Pharmacological agents affecting emesis: a review (part II). Drugs 1992;43:443-463
12. Hanson JS, McCallum RW. The diagnosis and management of nausea and vomiting: a review. Am J Gastroenterol 1985;80:210-218
13. Naylor RJ, Inall FC. The physiology and pharmacology of postoperative nausea and vomiting. Anaesthesia 1994;49:2-5
14. Newman V, Fullerton TJ, Anderson PO. Clinical advances in the management of severe nausea and vomiting during pregnancy. J Obstet Gynecol Neonatal Nurs 1993;22:483-490
15. Palazzo MGA, Strunin L. Anaesthesia and emesis: I. Etiology. Can Anaesth Soc J 1984;31:178-187
16. Peroutka SJ, Synder SH. Antiemetics: neurotransmitter receptor binding predicts therapeutic action. Lancet 1982;1:658-659
17. Gold BS, Kitz DS, Lecky JH, et al. Unanticipated admission to the hospital following ambulatory surgery. JAMA 1989;262:3008-3010
18. Macario A, Weiger M, Carney S, et al. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999;89:652-658
19. van Wijk MGF, Smalhout B. A postoperative analysis of the patient's view of anaesthesia in a Netherlands' teaching hospital. Anaesthesia 1990;45:679-682
20. McCarthy BG, Peroutka SJ. Differentiation of the muscarinic cholinergic receptor subtypes in human cortex and pons: implications for anti-motion sickness therapy. Aviat Space Environ Med 1988;49:63-66
21. McEvoy GK. AHSF Drug Information. Bethesda, MD: American Society of Hospital Pharmacists; 1990:608-611
22. Hardman JG, Limbird LE, Gilman A. The Pharmacological Basis of Therapeutic. 10th ed. New York: McGraw-Hill; 2001:155-171.
23. Dundee JW, Kirwan MK, Clarke RSJ. Anaesthesia and premedication as factors in postoperative vomiting. Acta Anaesthesiol Scand 1965;9:223-231
24. Loper KA, Ready LB, Dorman BH. Prophylactic transdermal scopolamine patches reduce nausea in postoperative patients receiving epidural morphine. Anesth Analg 1989;68:144-146
25. Kotelko DM, Rottman RL, Wright WC, et al. Transdermal scopolamine decreases nausea and vomiting following cesarean section in patients receiving epidural morphine. Anesthesiology 1989;71:675-678
26. Golding JF, Scott JR. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997;43:633-637
27. Tigerstedt I, Salmela L, Aromaa U. Double-blind comparison of transdermal scopolamine, droperidol and placebo against postoperative nausea and vomiting. Acta Anaesthesiol Scand 1988;32:454-457
28. Koski EMJ, Mattila MAK, Knapik D, et al. Double-blind comparison of transdermal hyoscine and placebo for the prevention of postoperative nausea. Br J Anaesth 1990;64:16-20
29. Kranke P, Morin AM, Roewer N, et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002;95:133-143
30. Clissold SP, Heel RC. Transdermal hyoscine (scopolamine): a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985;29:189-207
31. Aronson JK, Sear JW. Transdermal hyoscine (scopolamine) and postoperative vomiting [editorial]. Anaesthesia 1986;41:1-3
32. Bailey PL, Streisand JB, Pace NL, et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology 1990;72:977-980
33. Horimoto Y, Tomie H, Hanzawa K, et al. Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgery. Can J Anaesth 1991;38:441-444
34. Doyle E, Byers G, McNicol LR, et al. Prevention of postoperative nausea and vomiting with transdermal hyoscine in children using patient-controlled analgesia. Br J Anaesth 1994;72:72-76
35. Gibbons PA, Nicolson SC, Betts EK, et al. Scopolamine does not prevent postoperative emesis after pediatric eye surgery. Anesthesiology 1984;61:A435
36. Hardman JG, Limbird LE, Gilman A. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001:1023-1028
37. Harrington RA, Hamilton CW, Brogden RM, et al. Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 1983;25:451-494
38. Pinder RM, Brogden RN, Sawyer PR, et al. Metoclopramide: a review of its pharmacological properties and clinical use. Drugs 1976;12:81-131
39. Gralla RJ. Metoclopramide. A review of antiemetic trials. Drugs 1983;25:63-73
40. Kris MG, Tyson LB, Gralla RJ, et al. Extrapyramidal reactions with high dose metoclopramide [letter}. N Engl J Med 1983;309:433
41. Allen JC, Gralla RJ, Reilly C, et al. Metoclopramide: dose related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 1985;3:1136-1141
42. Leung AKC, Lai PCW. Use of metoclopramide for the treatment of gastroesophageal reflux in infants and children. Curr Ther Res 1984;36:911-915
43. Henzi I, Walder B, Tramer MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 1999;83:761-771
44. Cooke RD, Comyn DJ, Ball RW. Prevention of postoperative nausea and vomiting by domperidone: a double-blind randomized study using domperidone, metoclopramide and a placebo. S Afr Med J 1979;17:827-829
45. Boghaert A, Carron D, Gallant J, et al. Postoperative vomiting treated with domperidone: a double-blind comparison with metodopramide and a placebo. Acta Anesthesiol Belg 1980;31:129-137
46. Corssen G, Reves JG, Stanley TH. Neuroleptanalgesia and neuroleptanesthesia. In: Intravenous Anesthesia and Analgesia. Philadelphia, PA: Lea and Febiger; 1988:175
47. Janssen PAJ. The pharmacology of haloperidol. Int J Neuropsychiatry 1967;3(suppl 1):10
48. Borison HL, Wang SC. Physiology and pharmacology of vomiting. Pharmacol Rev 1953;5:193-230
49. Robbins EL, Nagel JD. Haloperidol parenterally for treatment of vomiting and nausea from gastrointestinal disorders in a group of geriatric patients: double-blind, placebo-controlled study. J Am Geriatr Soc 1975;23:38-41
50. Loeser EA, Bennett G, Stanley TH, et al. Comparison of droperidol, haloperidol and prochlorperazine as postoperative antiemetics. Can Anaesth Soc J 1979;26:125-127
51. Ross WT, Franz JA. Prevention of postoperative nausea and vomiting by haloperdol or droperidol [abstract]. Anesth Analg 1990;70:S335
52. Tometta FJ. Double-blind evaluation of haloperidol for anti-emetic activity. Anesth Analg 1972;51:964-967
53. Barton MD, Libonati M, Cohen PJ. The use of haloperidol for treatment of postoperative nausea and vomiting: a double-blind, placebo-controlled trial. Anesthesiology 1975;42:508-512
54. Lehmann KA, Van Peer A, Ikonomakis M, et al. Pharmacokinetics of droperidol in surgical patients under different conditions of anaesthesia. Br J Anaesth 1988;61:297-301
55. Melnick B, Sawyer R, Karambelkar D, et al. Delayed side effects of droperidol after ambulatory general anesthesia. Anesth Analg 1989;69:748-751
56. Henzi I, Sondereggar J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anesth 2000;47:537-551
57. MedWatch November 2001 Safety-Related Drug Labeling Changes. INAPSINE (droperidol) injection [November 26, 2001: Akorn]. Available at: http://www.fda.gov/medwatch/SAFETY/2001/nov01.htm. Accessed December 18, 2001
58. Ahmed S. "Dear Health Care Professional" letter. Buffalo Grove, IL: Akorn, Inc., December 4, 2001
59. Fortney JT, Gan TJ, Graczyk S, et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg 1998;86:731-738
60. Markman M, Sheidler V, Ettinger DS, et al. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 1984;311:549-552
61. Goldstein D, Levi JA, Woods RL. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy. Oncology 1989;46:105-108
62. Rich W, Abdulhayoglu G, Di Saia PJ. Methylprednisone as antiemetic during cancer chemotherapy: a pilot study. Gynecol Oncol 1980;9:193-198
63. Harris AL. Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet 1982;1:714-716
64. Asboe V, Raeder JC, Groegaard B. Betamethasone reduces postoperative pain and nausea after ambulatory surgery. Anesth Analg 1998;87:319-323
65. Aouad MT, Siddik SS, Rizk LB, et al. The effect of dexamethasone on postoperative nausea and vomiting. Anesth Analg 2001;92:636-640
66. Coloma M, Duffy L, White P, et al. Dexamethasone facilitates discharge after outpatient anorectal surgery. Anesth Analg 2001;92:85-88
67. Fujii Y, Tanaka H, Toyooka H. The effects of dexamethasone on antiemetics in female patients undergoing gynecologic surgery. Anesth Analg 1997;85:913-917
68. Subramaniam B, Madan R, Sadhasivam S, et al. Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair. Br J Anaesth 2001;86:84-89
69. Wang J, Ho S, Lee S, et al. The prophylactic effect of dexamethasone of postoperative nausea and vomiting in women undergoing thyroidectomy: a comparison of droperidol with saline. Anesth Analg 1999;89:200-203
70. Wang JJ, Ho ST, Liu YH, et al. Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth 1999;83:772-775
71. Wang JJ, Ho ST, Lee SC, et al. The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study. Anesth Analg 2000;91:1404-1407
72. Liu K, Hsu CC, Chia YY. The effect of dose of dexamethasone for antiemesis after major gynecological surgery. Anesth Analg 1999;89:1316-1318
73. Henzi I, Walder B, Tramer M. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90:186-194
74. Huang JC, Shieh JP, Tang CS, et al. Low-dose dexamethasone effectively prevents postoperative nausea and vomiting after ambulatory laparoscopic surgery. Can J Anaesth 2001;48:973-977
75. Wang JJ, Ho ST, Tzeng JI, et al. The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg 2000;91:136-139
76. Baldessaraini RJ. Drugs and the treatment of psychiatric disorders. In: Goodman L, Gillman A, eds. The Pharmaceutical Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990:387
77. Howatt DDC. Antiemetic drugs in anaesthesia: double blind trial of two phenothiazine derivatives. Anaesthesia 1960;15:289-297
78. Dundee JW, Moore J, Love WJ, et al. Studies of drugs given before anaesthesia. VI. The phenothiazine derivatives. Br J Anaesth 1965;37:332-352
79. Dundee JW, Assaf RAE, Loan WB, et al. A comparison of the efficacy of cyclizine and perphenazine in reducing the emetic effects of morphine and pethidine. Br J Clin Pharmacol 1975;2:81-85
80. Adams VR, Valley AW. Granisetron: the second serotonin-receptor antagonist. Ann Pharmacother 1995;29:1240-1251
81. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health-Syst Pharm 1999;56:729-764
82. Gyermek L. 5-HT(3) receptors: pharmacologic and therapeutic aspects. J Clin Pharmacol 1995;35:845-855
83. Herrstedt J. Development of antiemetic therapy in cancer patients. Acta Oncologica 1995;34:637-640
84. McKenzie R, Kovac A, O'Connor T, et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993;78:21-28
85. Tramer MR, Reynolds JM, Moore, RA, et al. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting. A quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997;87:1277-1289
86. 3 antagonist ondansetron. Anesthesiology 1993;78:15-20
87. Tramer MR, Moore RA, Reynolds DJM, et al. A quantitative systematic review of ondansetron in treatment of established postoperative nausea and vomiting. Br Med J 1997;314:1088-1092
88. Graczyk SG, McKenzie R, Kallar S, et al. Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery. Anesth Analg 1997;84:325-330
89. Kovac AL, Scuderi PE, Boerner TF, et al. Treatment of postoperative nausea and vomiting with single intravenous doses of dolasetron mesylate: a multicenter trial. Anesth Analg 1997;85:546-552
90. Fujii Y, Saitoh Y, Tanaka H, et al. Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg 2000;90:472-475
91. McKenzie R, Tantisira B, Karambelkar DJ, et al. Comparison of ondansetron with ondansetron plus dexamethasone in the prevention of postoperative nausea and vomiting. Anesth Analg 1994;79:961-964
92. McKenzie R, Uy NTL, Riley TJ, et al. Droperidol/ondansetron combination controls nausea and vomiting after tubal banding. Anesth Analg 1996;93:1218-1222
93. 3 receptor antagonists with droperidol or dexamethasone more effective than each agent alone for PONV prophylaxis? Available at: http://www.asa-abstracts.com. Accessed May 10, 2002
94. Fujii Y, Toyooka H, Tanaka H. Prevention of postoperative nausea and vomiting with a combination of granisetron and droperidol. Anesth Analg 1998;86:613-616
95. Fujii Tanaka H, Toyooka H. Granisetron-dexamethasone combination reduces postoperative nausea and vomiting. Can J Anaesth 1995;42:387-390
96. Coloma M, Markowitz SD, White PF, et al. Effect of dexamethasone on the prophylactic antiemetic activity of dolasetron. Available at: http//www.asa-abstracts.com. Accessed May 10, 2002
97. Steinbrook RA, Freiberger D, Gosnell JL, et al. Prophylactic antiemetic for laparoscopic cholecystectomy: ondansetron versus droperidol plus metoclopramide. Anesth Analg 1996;83:1081-1083
98. Scuderi PE, James RL, Harris L, et al. Multimodal management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 200;91:1408-1414